Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD

被引：13
作者：
Cannatelli, Rosanna [1 ]
Ferretti, Francesca [1 ]
Carmagnola, Stefania [1 ]
Bergna, Irene Maria Bambina [1 ]
Monico, Maria Camilla [1 ]
Maconi, Giovanni [1 ]
Ardizzone, Sandro [1 ]
机构：
[1] Univ Milan, Gastroenterol & Digest Endoscopy Unit, Dept Biochem & Clin Sci L Sacco, ASST Fatebenefratelli Sacco, Milan, Italy
来源：
GUT | 2022年 / 71卷 / 09期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1136/gutjnl-2021-326237
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1926 / 1928
页数：3
相关论文
共 9 条
  • [1] Adverse Events After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease
    Botwin, Gregory J.
    Li, Dalin
    Figueiredo, Jane
    Cheng, Susan
    Braun, Jonathan
    McGovern, Dermot P. B.
    Melmed, Gil Y.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (08) : 1746 - 1751
  • [2] How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
    Ferretti, Francesca
    Cannatelli, Rosanna
    Benucci, Maurizio
    Carmagnola, Stefania
    Clementi, Emilio
    Danelli, Piergiorgio
    Dilillo, Dario
    Fiorina, Paolo
    Galli, Massimo
    Gallieni, Maurizio
    Genovese, Giovanni
    Giorgi, Valeria
    Invernizzi, Alessandro
    Maconi, Giovanni
    Maier, Jeanette A.
    Marzano, Angelo V.
    Morpurgo, Paola S.
    Nebuloni, Manuela
    Radovanovic, Dejan
    Riva, Agostino
    Rizzardini, Giuliano
    Sabiu, Gianmarco
    Santus, Pierachille
    Staurenghi, Giovanni
    Zuccotti, Gianvincenzo
    Sarzi-Puttini, Pier Carlo
    Ardizzone, Sandro
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers
    Kadali, Renuka A. K.
    Janagama, Ravali
    Peruru, Sharanya
    Malayala, Srikrishna, V
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 106 : 376 - 381
  • [4] Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
    Kennedy, Nicholas A.
    Lin, Simeng
    Goodhand, James R.
    Chanchlani, Neil
    Hamilton, Benjamin
    Bewshea, Claire
    Nice, Rachel
    Chee, Desmond
    Cummings, J. R. Fraser
    Fraser, Aileen
    Irving, Peter M.
    Kamperidis, Nikolaos
    Kok, Klaartje B.
    Lamb, Christopher Andrew
    Macdonald, Jonathan
    Mehta, Shameer
    Pollok, Richard C. G.
    Raine, Tim
    Smith, Philip J.
    Verma, Ajay Mark
    Jochum, Simon
    McDonald, Timothy J.
    Sebastian, Shaji
    Lees, Charlie W.
    Powell, Nick
    Ahmad, Tariq
    [J]. GUT, 2021, 70 (10) : 1884 - 1893
  • [5] Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
    Kennedy, Nicholas A.
    Goodhand, James R.
    Bewshea, Claire
    Nice, Rachel
    Chee, Desmond
    Lin, Simeng
    Chanchlani, Neil
    Butterworth, Jeffrey
    Cooney, Rachel
    Croft, Nicholas M.
    Hart, Ailsa L.
    Irving, Peter M.
    Kok, Klaartje B.
    Lamb, Christopher A.
    Limdi, Jimmy K.
    Macdonald, Jonathan
    McGovern, Dermot Pb
    Mehta, Shameer J.
    Murray, Charles D.
    Patel, Kamal, V
    Pollok, Richard C. G.
    Raine, Timothy
    Russell, Richard K.
    Selinger, Christian P.
    Smith, Philip J.
    Bowden, Jack
    McDonald, Timothy J.
    Lees, Charlie W.
    Sebastian, Shaji
    Powell, Nicholas
    Ahmad, Tariq
    [J]. GUT, 2021, 70 (05) : 865 - 875
  • [6] Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
    Maconi, Giovanni
    Bosetti, Cristina
    De Monti, Alberta
    Boyapati, Ray Kiran
    Shelton, Edward
    Piazza, Nicole
    Gabrielli, Anna Maria Carvalhas
    Lenti, Marco Vincenzo
    Bezzio, Cristina
    Ricci, Chiara
    Greco, Salvatore
    Romeo, Samanta
    Giangregorio, Francesco
    Gridavilla, Daniele
    Tagliani, Fabio
    Massari, Alessandro
    Pastorelli, Luca
    Di Sabatino, Antonio
    Saibeni, Simone
    Alicante, Saverio
    Ferretti, Francesca
    Rizzardini, Giuliano
    Galli, Massimo
    Ardizzone, Sandro
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 (03) : 263 - 270
  • [7] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) : 2603 - 2615
  • [8] H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy
    Rahier, Jean-Francois
    Papay, Pavol
    Salleron, Julia
    Sebastian, Shaji
    Marzo, Manuela
    Peyrin-Biroulet, Laurent
    Garcia-Sanchez, Valle
    Fries, Walter
    van Asseldonk, Dirk P.
    Farkas, Klaudia
    de Boer, Nanne K.
    Sipponen, Taina
    Ellul, Pierre
    Louis, Edouard
    Peake, Simon T. C.
    Kopylov, Uri
    Maul, Jochen
    Makhoul, Badira
    Fiorino, Gionata
    Yazdanpanah, Yazdan
    Chaparro, Maria
    [J]. GUT, 2011, 60 (04) : 456 - 462
  • [9] SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
    Siegel, Corey A.
    Melmed, Gil Y.
    McGovern, Dermot P. B.
    Rai, Victoria
    Krammer, Florian
    Rubin, David T.
    Abreu, Maria T.
    Dubinsky, Marla C.
    [J]. GUT, 2021, 70 (04) : 635 - +
1